Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

11 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Safety and survival outcomes for bloodless transplantation in patients with myeloma.
Joseph NS, Kaufman JL, Boise LH, Valla K, Almaula DK, Obidike CO, Langston AA, Waller EK, Khoury HJ, Flowers CR, Graiser M, Heffner LT, Lonial S, Nooka AK. Joseph NS, et al. Among authors: Graiser M. Cancer. 2019 Jan 15;125(2):185-193. doi: 10.1002/cncr.31677. Epub 2018 Nov 27. Cancer. 2019. PMID: 30480777 Free article.
Pharmacokinetic-directed high-dose busulfan combined with cyclophosphamide and etoposide results in predictable drug levels and durable long-term survival in lymphoma patients undergoing autologous stem cell transplantation.
Zhang H, Graiser M, Hutcherson DA, Dada MO, McMillan S, Ali Z, Flowers CR, Waller EK. Zhang H, et al. Among authors: Graiser M. Biol Blood Marrow Transplant. 2012 Aug;18(8):1287-94. doi: 10.1016/j.bbmt.2012.02.006. Epub 2012 Feb 25. Biol Blood Marrow Transplant. 2012. PMID: 22370160 Free article.
Myeloablative busulfan/cytoxan conditioning versus reduced-intensity fludarabine/melphalan conditioning for allogeneic hematopoietic stem cell transplant in patients with acute myelogenous leukemia.
Dhere V, Edelman S, Waller EK, Langston A, Graiser M, Connolly EC, Switchenko JM, Esiashvili N, Khan MK. Dhere V, et al. Among authors: Graiser M. Leuk Lymphoma. 2018 Apr;59(4):837-843. doi: 10.1080/10428194.2017.1361027. Epub 2017 Aug 7. Leuk Lymphoma. 2018. PMID: 28782395 Free PMC article.
Similar survival for patients undergoing reduced-intensity total body irradiation (TBI) versus myeloablative TBI as conditioning for allogeneic transplant in acute leukemia.
Mikell JL, Waller EK, Switchenko JM, Rangaraju S, Ali Z, Graiser M, Hall WA, Langston AA, Esiashvili N, Khoury HJ, Khan MK. Mikell JL, et al. Among authors: Graiser M. Int J Radiat Oncol Biol Phys. 2014 Jun 1;89(2):360-9. doi: 10.1016/j.ijrobp.2014.02.032. Epub 2014 May 5. Int J Radiat Oncol Biol Phys. 2014. PMID: 24837891
Favorable impact of pre-transplant ATG on outcomes of reduced-intensity hematopoietic cell transplants from partially mismatched unrelated donors.
Langston AA, Prichard JM, Muppidi S, Nooka A, Lechowicz MJ, Lonial S, Sinha R, Graiser M, Kaufman JL, Khoury HJ, Flowers CR, Waller EK. Langston AA, et al. Among authors: Graiser M. Bone Marrow Transplant. 2014 Feb;49(2):185-9. doi: 10.1038/bmt.2013.168. Epub 2013 Oct 28. Bone Marrow Transplant. 2014. PMID: 24162613
Pharmacoeconomic analysis of palifermin to prevent mucositis among patients undergoing autologous hematopoietic stem cell transplantation.
Nooka AK, Johnson HR, Kaufman JL, Flowers CR, Langston A, Steuer C, Graiser M, Ali Z, Shah NN, Rangaraju S, Nickleach D, Gao J, Lonial S, Waller EK. Nooka AK, et al. Among authors: Graiser M. Biol Blood Marrow Transplant. 2014 Jun;20(6):852-857. doi: 10.1016/j.bbmt.2014.02.025. Epub 2014 Mar 6. Biol Blood Marrow Transplant. 2014. PMID: 24607557 Free PMC article.
Peritransplantation Red Blood Cell Transfusion Is Associated with Increased Risk of Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation.
Hosoba S, Waller EK, Shenvi N, Graiser M, Easley KA, Al-Kadhimi Z, Andoh A, Antun AG, Barclay S, Josephson CD, Koff JL, Khoury HJ, Langston AA, Zimring JC, Roback JD, Giver CR. Hosoba S, et al. Among authors: Graiser M. Biol Blood Marrow Transplant. 2018 May;24(5):973-982. doi: 10.1016/j.bbmt.2018.01.003. Epub 2018 Jan 4. Biol Blood Marrow Transplant. 2018. PMID: 29307717 Free PMC article.
11 results
Jump to page
Feedback